The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis

被引:10
|
作者
Cirino, Allison L. [1 ,2 ]
Harris, Stephanie L. [3 ]
Murad, Andrea M. [4 ]
Hansen, Brittany [5 ]
Malinowski, Jennifer [6 ]
Natoli, Jaime L. [7 ]
Kelly, Melissa A. [8 ]
Christian, Susan [9 ]
机构
[1] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA
[2] MGH Inst Hlth Profess, 36 First Ave, Boston, MA 02129 USA
[3] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Genet Program, Boston, MA USA
[4] Univ Michigan, Div Med Genet, Dept Internal Med, Ann Arbor, MI USA
[5] Cleveland Clin, Genom Med Inst, Ctr Personalized Genet Healthcare, Cleveland, OH USA
[6] Write Inscite South Salem, New York, NY USA
[7] Kaiser Permanente, Southern Calif Permanente Med Grp, Pasadena, CA USA
[8] Genom Med Inst, Geisinger, Danville, PA USA
[9] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada
关键词
cascade testing; genetic counseling; genetic testing; hypertrophic cardiomyopathy; predictive genetic testing; systematic review; utility; QUALITY-OF-LIFE; FOLLOW-UP; MUTATION CARRIERS; RELATIVES; CHILDREN; RISK; IMPACT; POPULATION; PENETRANCE; KNOWLEDGE;
D O I
10.1002/jgc4.1604
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic testing and genetic counseling are routinely indicated for patients with hypertrophic cardiomyopathy (HCM); however, the uptake and utility of these services is not entirely understood. This systematic review and meta-analysis summarizes the uptake and utility of genetic counseling and genetic testing for patients with HCM and their at-risk family members, as well as the impact of genetic counseling/testing on patient-reported outcomes (PROs). A systematic search was performed through March 12, 2021. Meta-analyses were performed whenever possible; other findings were qualitatively summarized. Forty-eight studies met inclusion criteria (47 observational, 1 randomized). Uptake of genetic testing in probands was 57% (95% confidence interval [CI]: 40, 73). Uptake of cascade screening for at-risk relatives were as follows: 61% for cascade genetic testing (95% CI: 45, 75), 58% for cardiac screening (e.g. echocardiography) (95% CI: 40, 73), and 69% for either/both approaches (95% CI: 43, 87). In addition, relatives of probands with a positive genetic test result were significantly more likely to undergo cascade screening compared to relatives of probands with a negative result (odds ratio = 3.17, 95% CI: 2.12, 4.76). Overall, uptake of genetic counseling in both probands and relatives ranged from 37% to 84%. Multiple studies found little difference in PROs between individuals receiving positive versus negative genetic test results; however, other studies found that individuals with positive genetic test results experienced worse psychological outcomes. Genetic testing may also inform life choices, particularly decisions related to reproduction and insurance. Genetic counseling was associated with high satisfaction, increased perceived personal control and empowerment, and decreased anxiety. Approximately half to three-quarters of patients with HCM and their relatives undergo genetic testing or cascade screening. PROs after genetic testing varied and genetic counseling was associated with high satisfaction and improved PROs.
引用
收藏
页码:1290 / 1305
页数:16
相关论文
共 50 条
  • [41] Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Systematic Review and Meta-analysis of Anticoagulation Strategy
    Oliveri, Federico
    Pepe, Antonella
    Bongiorno, Andrea
    Fasolino, Alessandro
    Gentile, Francesca Romana
    Schirinzi, Sandra
    Colombo, Davide
    Breviario, Federico
    Greco, Alessandra
    Turco, Annalisa
    Acquaro, Mauro
    Tua, Lorenzo
    Scelsi, Laura
    Ghio, Stefano
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (03) : 269 - 276
  • [42] Prognostic Impact of Atrial Fibrillation in Hypertrophic Cardiomyopathy - A Systematic Review and Meta-Analysis
    Alphonse, Patricia
    Virk, Sohaib
    Collins, Jhonna
    Kumar, Saurabh
    CIRCULATION, 2018, 138
  • [43] Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
    Bayonas-Ruiz, Adrian
    Munoz-Franco, Francisca M.
    Ferrer, Vicente
    Perez-Caballero, Carlos
    Sabater-Molina, Maria
    Tome-Esteban, Maria Teresa
    Bonacasa, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [44] Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis
    Providencia, Rui
    Elliott, Perry
    Patel, Kiran
    McCready, Jack
    Babu, Girish
    Srinivasan, Neil
    Bronis, Kostantinos
    Papageorgiou, Nikolaos
    Chow, Anthony
    Rowland, Edward
    Lowe, Martin
    Segal, Oliver R.
    Lambiase, Pier D.
    HEART, 2016, 102 (19) : 1533 - 1543
  • [45] Gender-Related Differences in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
    Trongtorsak, Angkawipa
    Polpichai, Natchaya
    Thangjui, Sittinun
    Kewcharoen, Jakrin
    Yodsuwan, Ratdanai
    Devkota, Amrit
    Friedman, Harvey J.
    Estrad, Alfonso Q.
    PULSE, 2021, 9 (1-2) : 38 - 46
  • [46] A Systematic Review and Meta-analysis of Efficacy and Safety of Mavacamten for the Treatment of Hypertrophic Cardiomyopathy
    Zheng, Li
    Gu, Xiaotong
    Chen, Yumiao
    Liu, Deping
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (10)
  • [47] Subcutaneous Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
    Oliveira, Vinicius M.
    Oliveira, Izadora C.
    Menezes Junior, Antonio da Silva
    CIRCULATION, 2023, 148
  • [48] A systematic review and meta-analysis of sex differences in clinical outcomes of hypertrophic cardiomyopathy
    Liu, Guyue
    Su, Li
    Lang, Mingjian
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [49] Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis
    Canzi, Camila Cassia
    do Prado Junior, Edivalde Ribeiro
    Menezes Junior, Antonio da Silva
    Rezende, Aline Lazara
    Botelho, Silvia Marcal
    Santo, Luciana da Ressurreica
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 24
  • [50] Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis
    Mascia, Giuseppe
    Crotti, Lia
    Groppelli, Antonella
    Canepa, Marco
    Merlo, Andrea Carlo
    Benenati, Stefano
    Di Donna, Paolo
    Della Bona, Roberta
    Soranna, Davide
    Zambon, Antonella
    Porto, Italo
    Olivotto, Iacopo
    Parati, Gianfranco
    Brignole, Michele
    Cecchi, Franco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 357 : 88 - 94